- Home
- OPTX vs MIST Comparison
OPTX vs MIST Comparison
Compare OPTX & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPTX
- MIST
- Stock Information
- Founded
- OPTX 1981
- MIST 2003
- Country
- OPTX United States
- MIST Canada
- Employees
- OPTX N/A
- MIST N/A
- Industry
- OPTX Blank Checks
- MIST Biotechnology: Pharmaceutical Preparations
- Sector
- OPTX Finance
- MIST Health Care
- Exchange
- OPTX Nasdaq
- MIST Nasdaq
- Market Cap
- OPTX 51.9M
- MIST 53.9M
- IPO Year
- OPTX N/A
- MIST N/A
- Fundamental
- Price
- OPTX $1.66
- MIST $1.62
- Analyst Decision
- OPTX
- MIST Strong Buy
- Analyst Count
- OPTX 0
- MIST 2
- Target Price
- OPTX N/A
- MIST $9.50
- AVG Volume (30 Days)
- OPTX 56.1K
- MIST 994.4K
- Earning Date
- OPTX 06-13-2025
- MIST 05-14-2025
- Dividend Yield
- OPTX N/A
- MIST N/A
- EPS Growth
- OPTX N/A
- MIST N/A
- EPS
- OPTX 0.00
- MIST N/A
- Revenue
- OPTX $29,392,186.00
- MIST N/A
- Revenue This Year
- OPTX N/A
- MIST N/A
- Revenue Next Year
- OPTX N/A
- MIST N/A
- P/E Ratio
- OPTX $997.14
- MIST N/A
- Revenue Growth
- OPTX 4.36
- MIST N/A
- 52 Week Low
- OPTX $0.85
- MIST $0.63
- 52 Week High
- OPTX $8.39
- MIST $2.75
- Technical
- Relative Strength Index (RSI)
- OPTX 56.12
- MIST 60.67
- Support Level
- OPTX $1.33
- MIST $1.39
- Resistance Level
- OPTX $1.85
- MIST $1.60
- Average True Range (ATR)
- OPTX 0.16
- MIST 0.11
- MACD
- OPTX 0.02
- MIST 0.03
- Stochastic Oscillator
- OPTX 56.90
- MIST 86.60
About OPTX Syntec Optics Holdings Inc.
Syntec Optics Holdings Inc is vertically integrated from design and component manufacturing for lens system assembly to imaging module integration for system solutions. Making its tools, molding, and nano machining allows close interaction and recut ability, enabling special techniques to hold tolerances to sub-micron levels. It has steadily developed a variety of other complementary manufacturing techniques to provide a wide suite of horizontal capabilities including thin film deposition coatings, glass molding, polymer molding, tool-making, mechanical manufacturing, and nano machining.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).